文献速递瓣膜病与结构性心脏病心律失常

原发性二尖瓣反流伴或不伴脱垂患者的心肌纤维化

Myocardial Fibrosis in Patients With Primary Mitral Regurgitation With and Without Prolapse.
PubMed 文献 · J Am Coll Cardiol · 2018-01-01

本研究纳入356例慢性原发性二尖瓣反流患者,用对比增强心血管磁共振评估左室纤维化。二尖瓣脱垂组左室纤维化比例显著高于非脱垂组(36.7% vs. 6.7%,p<0.001),脱垂与纤维化关联最强(OR 6.82,p<0.001)。随访中位1354天,脱垂合并纤维化患者心律失常事件发生率最高。

要点

  • 原发性二尖瓣反流中,二尖瓣脱垂者左室纤维化显著多于非脱垂者。
  • 二尖瓣脱垂与左室纤维化的关联在多变量校正后仍最强。
  • 脱垂合并左室纤维化者心律失常事件风险最高,纤维化或为风险标志。

核心结论

  • 原发性二尖瓣反流患者中,左室纤维化在二尖瓣脱垂者中比非脱垂者更常见,提示脱垂存在容量负荷之外的特殊病理生理机制。
  • 原发性二尖瓣反流中的左室纤维化可能是心律失常事件的风险标志。

研究设计与样本

  • 研究为对慢性原发性二尖瓣反流患者进行对比增强心血管磁共振评估的队列研究,共纳入356例患者(二尖瓣脱垂组177例,非脱垂组179例)。
  • 二尖瓣脱垂定义为 cine-CMR 上二尖瓣叶移位>2 mm;患者接受心脏重构、二尖瓣反流严重程度及左室替代性纤维化的综合评估,并随访心律失常事件。

主要发现

  • 左室纤维化在二尖瓣脱垂组比非脱垂组更常见(36.7% vs. 6.7%;p < 0.001)。
  • 校正临床变量、心脏重构指标及二尖瓣反流严重程度后,二尖瓣脱垂与左室纤维化关联最强(比值比:6.82;p < 0.001)。
  • 随访中位1354天期间,合并左室纤维化的二尖瓣脱垂患者心律失常事件发生率最高。

关键数值与推荐

  • 二尖瓣脱垂判定标准为 cine-CMR 上二尖瓣叶移位>2 mm。
  • 左室纤维化患病率:脱垂组36.7%,非脱垂组6.7%(p < 0.001)。
  • 二尖瓣脱垂与左室纤维化的校正比值比为6.82(p < 0.001)。
  • 随访中位时间为1354天。

临床怎么用

  • 对原发性二尖瓣反流患者应评估是否合并二尖瓣脱垂,脱垂者需警惕左室纤维化。
  • 可考虑用心血管磁共振识别左室纤维化,以辅助心律失常风险评估。
  • 合并左室纤维化的二尖瓣脱垂患者可能需要更密切的心律失常监测。

局限性

  • 原文摘要未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent studies reported left ventricular (LV) fibrosis in patients with primary mitral regurgitation (MR) thought to be principally due to mitral valve prolapse (MVP). OBJECTIVES: This study sought to evaluate the prevalence, characteristics, and prognostic implications of LV fibrosis in a large cohort of primary MR patients with and without MVP using cardiovascular magnetic resonance (CMR). METHODS: Patients referred for contrast CMR assessment of chronic primary MR were enrolled and underwent comprehensive assessment of cardiac remodeling, severity of MR, and LV replacement fibrosis. Primary MR patients were stratified into: an MVP group if there was >2 mm mitral leaflet displacement on cine-CMR, or a non-MVP group. Patients were followed for arrhythmic events (sudden cardiac death, aborted sudden cardiac arrest, and sustained or inducible ventricular arrhythmia). RESULTS: A total of 356 primary MR patients (177 MVP and 179 non-MVP) were enrolled. LV fibrosis was more prevalent in the MVP group than the non-MVP group (36.7% vs. 6.7%; p < 0.001). The presence of MVP had the strongest association (odds ratio: 6.82; p < 0.001) with LV fibrosis even after adjustment for clinical variables, measures of cardiac remodeling, and MR severity. During follow-up (median 1,354 days), MVP patients with LV fibrosis had the highest event rate for arrhythmic events. CONCLUSIONS: In primary MR patients, LV fibrosis is more prevalent in MVP than non-MVP, suggesting a unique pathophysiology beyond volume overload in MVP. LV fibrosis in primary MR may represent a risk marker of arrhythmic events.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Kitkungvan D, Nabi F, Kim RJ, et al. Myocardial Fibrosis in Patients With Primary Mitral Regurgitation With and Without Prolapse. J Am Coll Cardiol. 2018. PMID: 30115220. doi:10.1016/j.jacc.2018.06.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。